glutathione rapta c Tumor-targeted oxidation catalysis with ruthenium nanoreactors against hypoxic osteosarcoma Anticancer activity of RAPTA-EA1 in
Anticancer activity of RAPTA EA1 in triple negative BRCA1 proficient breast cancer cells: single and combined treatment with the PARP inhibitor olaparib ScienceDirect The Role of Metallodrugs in Enhancing Neuroendocrine Neoplasm Therapies: The Promising Anticancer Potential of Ruthenium Based Complexes Organoruthenium Prodrugs as a New Class of Cholinesterase and GlutathioneSTransferase Inhibitors Ristovski 2018 ChemMedChem Wiley Online Library Altered DNA Binding and Amplification of Human Breast Cancer Suppressor Gene BRCA1 Induced by a Novel Antitumor Compound, [Ru(6 p phenylethacrynate)Cl2(pta)] Enhanced Delivery of the RAPTA C Macromolecular Chemotherapeutic by Conjugation to Degradable Polymeric Micelles Biomacromolecules Anti cancer organoruthenium( ii ) complexes and their interactions with cysteine and its analogues. A mass spectrometric study Dalton Transactions (RSC Publishing) DOI:10.1039 C8DT04350G
Pay in 4 interest-free payments of $6.42 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4





